Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 26,637 | 20,628 | 19,750 | 15,374 | 0 |
| Operating Income | -26,637 | -20,628 | -19,750 | -15,374 | N/A |
| Other Income | 5,866 | 3,147 | 2,701 | 2,867 | 0 |
| Pre-tax Income | -20,771 | -17,481 | -17,049 | -12,507 | 0 |
| Income Tax | 186 | N/A | N/A | 1 | N/A |
| Net Income Continuous | -20,957 | -17,481 | -17,049 | -12,508 | N/A |
| Net Income | $-20,957 | $-17,481 | $-17,049 | $-12,508 | $N/A |
| EPS Basic Total Ops | 35.50 | -1.60 | -19.01 | -18.94 | N/A |
| EPS Basic Continuous Ops | 35.52 | -1.60 | -19.01 | -18.95 | N/A |
| EPS Diluted Total Ops | 35.50 | -1.60 | -19.01 | -18.94 | N/A |
| EPS Diluted Continuous Ops | 35.52 | -1.60 | -19.01 | -18.95 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.39 | -1.60 | N/A | N/A | N/A |
| EBITDA(a) | $-26,622 | $-20,613 | $-19,737 | $-15,361 | $N/A |